Daudi细胞

Daudi、Daudi、Daudi细胞、Daudi细胞、Daudi人Burkitt淋巴瘤细胞

Cell line name Daudi

Synonyms DAUDI; NK-10A; NK-10a; NK 10a; NK10a; N; GM03190; GM3190; GM03190A; GM17346

Accession CVCL_0008

Resource Identification Initiative To cite this cell line use: Daudi (RRID:CVCL_0008)

Comments Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

Part of: COSMIC cell lines project.

Part of: Human variation panel.

Part of: LL-100 blood cancer cell line panel.

Part of: MD Anderson Cell Lines Project.

Population: African; Kenyan.

Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ=ACC-78).

Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).

Microsatellite instability: Instable (MSI-low) (Sanger).

Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

Omics: Deep antibody staining analysis.

Omics: Deep exome analysis.

Omics: Deep quantitative proteome analysis.

Omics: DNA methylation analysis.

Omics: Protein expression by reverse-phase protein arrays.

Omics: SNP array analysis.

Omics: Transcriptome analysis by microarray.

Omics: Transcriptome analysis by RNAseq.

Omics: Virome analysis using RNAseq.

Caution: TP53 mutation indicated incorrectly as being at c.637C>T in PubMed=2052620.

Misspelling: Duadi; Note=Occasionally.

Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.

Cell type: B-cell; CL=CL_0000236.

PubMed=7316467; DOI=10.1111/j.1469-1809.1980.tb00953.x

Povey S., Jeremiah S., Arthur E., Steel M., Klein G.

Differences in genetic stability between human cell lines from patients with and without lymphoreticular malignancy.

Ann. Hum. Genet. 44:119-133(1980)

 

PubMed=6935474; DOI=10.1093/jnci/66.2.239

Wright W.C., Daniels W.P., Fogh J.

Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis.

J. Natl. Cancer Inst. 66:239-247(1981)

 

PubMed=6286763; DOI=10.4049/jimmunol.129.3.1336

Benjamin D., Magrath I.T., Maguire R.T., Janus C., Todd-Kulikowsk H.D., Parsons R.G.

Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type.

J. Immunol. 129:1336-1342(1982)

 

PubMed=6806672; DOI=10.1038/298474a0

Lenoir G.M., Preud'homme J.-L., Bernheim A., Berger R.

Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma.

Nature 298:474-476(1982)

 

PubMed=6954533; DOI=10.1073/pnas.79.7.2194; PMCID=PMC346157

Westin E.H., Gallo R.C., Arya S.K., Eva A., Souza L.M., Baluda M.A., Aaronson S.A., Wong-Staal F.

Differential expression of the amv gene in human hematopoietic cells.

Proc. Natl. Acad. Sci. U.S.A. 79:2194-2198(1982)

 

PubMed=6186604; DOI=10.1007/BF00364753

de Preval C., Mach B.

The absence of beta 2-microglobulin in Daudi cells: active gene but inactive messenger RNA.

Immunogenetics 17:133-140(1983)

 

PubMed=11894933; DOI=10.1002/j.1460-2075.1983.tb01412.x; PMCID=PMC555120

Rosa F.M., Berissi H., Weissenbach J., Maroteaux L., Fellous M., Revel M.

The beta2-microglobulin mRNA in human Daudi cells has a mutated initiation codon but is still inducible by interferon.

EMBO J. 2:239-243(1983)

 

PubMed=6200433; DOI=10.1007/BF00364762

Brodsky F.M.

A matrix approach to human class II histocompatibility antigens: reactions of four monoclonal antibodies with the products of nine haplotypes.

Immunogenetics 19:179-194(1984)

 

PubMed=6231253; DOI=10.1002/ijc.2910330407

Ehlin-Henriksson B., Klein G.

Distinction between Burkitt lymphoma subgroups by monoclonal antibodies: relationships between antigen expression and type of chromosomal translocation.

Int. J. Cancer 33:459-463(1984)

 

PubMed=6500159; DOI=10.1159/000163283

Gershwin M.E., Lentz D., Owens R.B.

Relationship between karyotype of tissue culture lines and tumorigenicity in nude mice.

Exp. Cell Biol. 52:361-370(1984)

 

PubMed=6547209; DOI=10.1038/309592a0

Rabbitts T.H., Forster A., Hamlyn P.H., Baer R.

Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma.

Nature 309:592-597(1984)

 

PubMed=6582512; DOI=10.1073/pnas.81.2.568; PMCID=PMC344720

Mattes M.J., Cordon-Cardo C., Lewis J.L. Jr., Old L.J., Lloyd K.O.

Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.

Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984)

 

PubMed=6592381; DOI=10.1093/jnci/73.4.841

Favrot M.-C., Philip I., Philip T., Portoukalian J., Dore J.-F., Lenoir G.M.

Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin.

J. Natl. Cancer Inst. 73:841-847(1984)

 

PubMed=2985879; DOI=10.1016/0145-2126(85)90084-0

Drexler H.G., Gaedicke G., Minowada J.

Isoenzyme studies in human leukemia-lymphoma cell lines -- 1 carboxylic esterase.

Leuk. Res. 9:209-229(1985)

 

PubMed=2998993

Steel C.M., Morten J.E.N., Foster E.

The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.

IARC Sci. Publ. 60:265-292(1985)